In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global ...

Two monoclonal antibodies appeared safe and tolerable when administered alone or in combination to newborns exposed to HIV, according to a proof-of-concept study presented at the International AIDS ...

With the 2025 influenza season starting earlier than usual, the NICD urges South Africans to stay vigilant against seasonal ...

The flu season is ramping up with more cases, more hospital admissions and more patients sent to intensive care units.

WHO includes ArkBio' paediatric RSV drug, ziresovir in PADO-RSV priority list: Shanghai, China Thursday, July 17, 2025, 14:00 Hrs [IST] Shanghai Ark Biopharmaceutical Co., Ltd. (A ...

The offering, the first IPO this year, attracted more than 32 billion dirhams ($3.5 bln) in demand for 500 million dirhams in shares. GSK seeks FDA nod for expanded use of RSV vaccine in adults ...

Nigeria carries the highest burden of cervical cancer in Africa and ranks seventh globally, with an estimated 12,000 new ...

Kennedy selected a new team of medical professionals and scientists who are highly qualified and dedicated to public health.

Multinational pharmaceutical company, MSD has renewed its commitment to strengthening healthcare access in Nigeria, calling ...

You’re not imagining it, flu cases are on the rise this season, as vaccination levels decline and COVID-style social ...

RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...